ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Infiltrating Lymphocyte (TIL) Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-25L12367
Home | Market Reports | Health| Health Conditions| Cancer
Global Tumor Infiltrating Lymphocyte TIL Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Tumor Infiltrating Lymphocyte (TIL) Market Research Report 2025

Code: QYRE-Auto-25L12367
Report
June 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Iovance Biotherapeutics
TILT Biotherapeutics
Lion TCR
WuXi AppTec
Shanghai Juncell Therapeutics
Grit Biotechnology
Optera Therapeutics
KSQ Therapeutics
Beijing Chineo
AbelZeta Inc
Oricell Therapeutics
Guangzhou Biosyngen

Tumor Infiltrating Lymphocyte (TIL) Market

The global market for Tumor Infiltrating Lymphocyte (TIL) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tumor-Infiltrating Lymphocytes (TILs) are a type of immune cell that has migrated from the bloodstream into a tumor or cancerous lesion. These lymphocytes, primarily T cells but also including other types such as B cells, natural killer (NK) cells, and dendritic cells, play a critical role in the body's immune response against cancer. TIL therapy has emerged as a promising cancer treatment strategy, particularly in the field of immunotherapy. This involves isolating TILs from a patient's tumor, growing them in large numbers in a laboratory, and then re-infusing them back into the patient after sometimes augmenting them to enhance their anti-tumor capabilities. The goal is to amplify the immune response against the cancer, leading to tumor regression.
North American market for Tumor Infiltrating Lymphocyte (TIL) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Infiltrating Lymphocyte (TIL) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Tumor Infiltrating Lymphocyte (TIL) in Melanoma is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Tumor Infiltrating Lymphocyte (TIL) include IOVANCE Biotherapeutics, Optera Therapeutics, TILT Biotherapeutics, KSQ Therapeutics, Lion TCR, Beijing Chineo, AbelZeta Inc, WuXi AppTec, Oricell Therapeutics, Guangzhou Biosyngen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Infiltrating Lymphocyte (TIL), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Infiltrating Lymphocyte (TIL).
The Tumor Infiltrating Lymphocyte (TIL) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Infiltrating Lymphocyte (TIL) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Infiltrating Lymphocyte (TIL) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor Infiltrating Lymphocyte (TIL) Market Report

Report Metric Details
Report Name Tumor Infiltrating Lymphocyte (TIL) Market
Segment by Type
  • T-cells
  • B-cells
  • Natural Killer Cells
Segment by Application
  • Melanoma
  • Colon Cancer
  • Cervical Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IOVANCE Biotherapeutics, Optera Therapeutics, TILT Biotherapeutics, KSQ Therapeutics, Lion TCR, Beijing Chineo, AbelZeta Inc, WuXi AppTec, Oricell Therapeutics, Guangzhou Biosyngen, Shanghai Juncell Therapeutics, GRIT Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tumor Infiltrating Lymphocyte (TIL) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Infiltrating Lymphocyte (TIL) Market report?

Ans: The main players in the Tumor Infiltrating Lymphocyte (TIL) Market are IOVANCE Biotherapeutics, Optera Therapeutics, TILT Biotherapeutics, KSQ Therapeutics, Lion TCR, Beijing Chineo, AbelZeta Inc, WuXi AppTec, Oricell Therapeutics, Guangzhou Biosyngen, Shanghai Juncell Therapeutics, GRIT Biotechnology

What are the Application segmentation covered in the Tumor Infiltrating Lymphocyte (TIL) Market report?

Ans: The Applications covered in the Tumor Infiltrating Lymphocyte (TIL) Market report are Melanoma, Colon Cancer, Cervical Cancer, Others

What are the Type segmentation covered in the Tumor Infiltrating Lymphocyte (TIL) Market report?

Ans: The Types covered in the Tumor Infiltrating Lymphocyte (TIL) Market report are T-cells, B-cells, Natural Killer Cells

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Infiltrating Lymphocyte (TIL) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 T-cells
1.2.3 B-cells
1.2.4 Natural Killer Cells
1.3 Market by Application
1.3.1 Global Tumor Infiltrating Lymphocyte (TIL) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Melanoma
1.3.3 Colon Cancer
1.3.4 Cervical Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Infiltrating Lymphocyte (TIL) Market Perspective (2020-2031)
2.2 Global Tumor Infiltrating Lymphocyte (TIL) Growth Trends by Region
2.2.1 Global Tumor Infiltrating Lymphocyte (TIL) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Infiltrating Lymphocyte (TIL) Historic Market Size by Region (2020-2025)
2.2.3 Tumor Infiltrating Lymphocyte (TIL) Forecasted Market Size by Region (2026-2031)
2.3 Tumor Infiltrating Lymphocyte (TIL) Market Dynamics
2.3.1 Tumor Infiltrating Lymphocyte (TIL) Industry Trends
2.3.2 Tumor Infiltrating Lymphocyte (TIL) Market Drivers
2.3.3 Tumor Infiltrating Lymphocyte (TIL) Market Challenges
2.3.4 Tumor Infiltrating Lymphocyte (TIL) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Infiltrating Lymphocyte (TIL) Players by Revenue
3.1.1 Global Top Tumor Infiltrating Lymphocyte (TIL) Players by Revenue (2020-2025)
3.1.2 Global Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Infiltrating Lymphocyte (TIL) Revenue
3.4 Global Tumor Infiltrating Lymphocyte (TIL) Market Concentration Ratio
3.4.1 Global Tumor Infiltrating Lymphocyte (TIL) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Infiltrating Lymphocyte (TIL) Revenue in 2024
3.5 Global Key Players of Tumor Infiltrating Lymphocyte (TIL) Head office and Area Served
3.6 Global Key Players of Tumor Infiltrating Lymphocyte (TIL), Product and Application
3.7 Global Key Players of Tumor Infiltrating Lymphocyte (TIL), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Infiltrating Lymphocyte (TIL) Breakdown Data by Type
4.1 Global Tumor Infiltrating Lymphocyte (TIL) Historic Market Size by Type (2020-2025)
4.2 Global Tumor Infiltrating Lymphocyte (TIL) Forecasted Market Size by Type (2026-2031)
5 Tumor Infiltrating Lymphocyte (TIL) Breakdown Data by Application
5.1 Global Tumor Infiltrating Lymphocyte (TIL) Historic Market Size by Application (2020-2025)
5.2 Global Tumor Infiltrating Lymphocyte (TIL) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Infiltrating Lymphocyte (TIL) Market Size (2020-2031)
6.2 North America Tumor Infiltrating Lymphocyte (TIL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025)
6.4 North America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Infiltrating Lymphocyte (TIL) Market Size (2020-2031)
7.2 Europe Tumor Infiltrating Lymphocyte (TIL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025)
7.4 Europe Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Size (2020-2031)
8.2 Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Infiltrating Lymphocyte (TIL) Market Size (2020-2031)
9.2 Latin America Tumor Infiltrating Lymphocyte (TIL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025)
9.4 Latin America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Size (2020-2031)
10.2 Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IOVANCE Biotherapeutics
11.1.1 IOVANCE Biotherapeutics Company Details
11.1.2 IOVANCE Biotherapeutics Business Overview
11.1.3 IOVANCE Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Introduction
11.1.4 IOVANCE Biotherapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.1.5 IOVANCE Biotherapeutics Recent Development
11.2 Optera Therapeutics
11.2.1 Optera Therapeutics Company Details
11.2.2 Optera Therapeutics Business Overview
11.2.3 Optera Therapeutics Tumor Infiltrating Lymphocyte (TIL) Introduction
11.2.4 Optera Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.2.5 Optera Therapeutics Recent Development
11.3 TILT Biotherapeutics
11.3.1 TILT Biotherapeutics Company Details
11.3.2 TILT Biotherapeutics Business Overview
11.3.3 TILT Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Introduction
11.3.4 TILT Biotherapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.3.5 TILT Biotherapeutics Recent Development
11.4 KSQ Therapeutics
11.4.1 KSQ Therapeutics Company Details
11.4.2 KSQ Therapeutics Business Overview
11.4.3 KSQ Therapeutics Tumor Infiltrating Lymphocyte (TIL) Introduction
11.4.4 KSQ Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.4.5 KSQ Therapeutics Recent Development
11.5 Lion TCR
11.5.1 Lion TCR Company Details
11.5.2 Lion TCR Business Overview
11.5.3 Lion TCR Tumor Infiltrating Lymphocyte (TIL) Introduction
11.5.4 Lion TCR Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.5.5 Lion TCR Recent Development
11.6 Beijing Chineo
11.6.1 Beijing Chineo Company Details
11.6.2 Beijing Chineo Business Overview
11.6.3 Beijing Chineo Tumor Infiltrating Lymphocyte (TIL) Introduction
11.6.4 Beijing Chineo Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.6.5 Beijing Chineo Recent Development
11.7 AbelZeta Inc
11.7.1 AbelZeta Inc Company Details
11.7.2 AbelZeta Inc Business Overview
11.7.3 AbelZeta Inc Tumor Infiltrating Lymphocyte (TIL) Introduction
11.7.4 AbelZeta Inc Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.7.5 AbelZeta Inc Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Details
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Tumor Infiltrating Lymphocyte (TIL) Introduction
11.8.4 WuXi AppTec Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.8.5 WuXi AppTec Recent Development
11.9 Oricell Therapeutics
11.9.1 Oricell Therapeutics Company Details
11.9.2 Oricell Therapeutics Business Overview
11.9.3 Oricell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Introduction
11.9.4 Oricell Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.9.5 Oricell Therapeutics Recent Development
11.10 Guangzhou Biosyngen
11.10.1 Guangzhou Biosyngen Company Details
11.10.2 Guangzhou Biosyngen Business Overview
11.10.3 Guangzhou Biosyngen Tumor Infiltrating Lymphocyte (TIL) Introduction
11.10.4 Guangzhou Biosyngen Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.10.5 Guangzhou Biosyngen Recent Development
11.11 Shanghai Juncell Therapeutics
11.11.1 Shanghai Juncell Therapeutics Company Details
11.11.2 Shanghai Juncell Therapeutics Business Overview
11.11.3 Shanghai Juncell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Introduction
11.11.4 Shanghai Juncell Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.11.5 Shanghai Juncell Therapeutics Recent Development
11.12 GRIT Biotechnology
11.12.1 GRIT Biotechnology Company Details
11.12.2 GRIT Biotechnology Business Overview
11.12.3 GRIT Biotechnology Tumor Infiltrating Lymphocyte (TIL) Introduction
11.12.4 GRIT Biotechnology Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
11.12.5 GRIT Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Iovance Biotherapeutics
TILT Biotherapeutics
Lion TCR
WuXi AppTec
Shanghai Juncell Therapeutics
Grit Biotechnology
Optera Therapeutics
KSQ Therapeutics
Beijing Chineo
AbelZeta Inc
Oricell Therapeutics
Guangzhou Biosyngen
List of Tables
 Table 1. Global Tumor Infiltrating Lymphocyte (TIL) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of T-cells
 Table 3. Key Players of B-cells
 Table 4. Key Players of Natural Killer Cells
 Table 5. Global Tumor Infiltrating Lymphocyte (TIL) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Tumor Infiltrating Lymphocyte (TIL) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Tumor Infiltrating Lymphocyte (TIL) Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Region (2020-2025)
 Table 9. Global Tumor Infiltrating Lymphocyte (TIL) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Region (2026-2031)
 Table 11. Tumor Infiltrating Lymphocyte (TIL) Market Trends
 Table 12. Tumor Infiltrating Lymphocyte (TIL) Market Drivers
 Table 13. Tumor Infiltrating Lymphocyte (TIL) Market Challenges
 Table 14. Tumor Infiltrating Lymphocyte (TIL) Market Restraints
 Table 15. Global Tumor Infiltrating Lymphocyte (TIL) Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Players (2020-2025)
 Table 17. Global Top Tumor Infiltrating Lymphocyte (TIL) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Infiltrating Lymphocyte (TIL) as of 2024)
 Table 18. Ranking of Global Top Tumor Infiltrating Lymphocyte (TIL) Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Tumor Infiltrating Lymphocyte (TIL) Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Tumor Infiltrating Lymphocyte (TIL), Headquarters and Area Served
 Table 21. Global Key Players of Tumor Infiltrating Lymphocyte (TIL), Product and Application
 Table 22. Global Key Players of Tumor Infiltrating Lymphocyte (TIL), Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Tumor Infiltrating Lymphocyte (TIL) Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Type (2020-2025)
 Table 26. Global Tumor Infiltrating Lymphocyte (TIL) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Type (2026-2031)
 Table 28. Global Tumor Infiltrating Lymphocyte (TIL) Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Application (2020-2025)
 Table 30. Global Tumor Infiltrating Lymphocyte (TIL) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Application (2026-2031)
 Table 32. North America Tumor Infiltrating Lymphocyte (TIL) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Tumor Infiltrating Lymphocyte (TIL) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Tumor Infiltrating Lymphocyte (TIL) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Size by Country (2026-2031) & (US$ Million)
 Table 47. IOVANCE Biotherapeutics Company Details
 Table 48. IOVANCE Biotherapeutics Business Overview
 Table 49. IOVANCE Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Product
 Table 50. IOVANCE Biotherapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 51. IOVANCE Biotherapeutics Recent Development
 Table 52. Optera Therapeutics Company Details
 Table 53. Optera Therapeutics Business Overview
 Table 54. Optera Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product
 Table 55. Optera Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 56. Optera Therapeutics Recent Development
 Table 57. TILT Biotherapeutics Company Details
 Table 58. TILT Biotherapeutics Business Overview
 Table 59. TILT Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Product
 Table 60. TILT Biotherapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 61. TILT Biotherapeutics Recent Development
 Table 62. KSQ Therapeutics Company Details
 Table 63. KSQ Therapeutics Business Overview
 Table 64. KSQ Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product
 Table 65. KSQ Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 66. KSQ Therapeutics Recent Development
 Table 67. Lion TCR Company Details
 Table 68. Lion TCR Business Overview
 Table 69. Lion TCR Tumor Infiltrating Lymphocyte (TIL) Product
 Table 70. Lion TCR Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 71. Lion TCR Recent Development
 Table 72. Beijing Chineo Company Details
 Table 73. Beijing Chineo Business Overview
 Table 74. Beijing Chineo Tumor Infiltrating Lymphocyte (TIL) Product
 Table 75. Beijing Chineo Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 76. Beijing Chineo Recent Development
 Table 77. AbelZeta Inc Company Details
 Table 78. AbelZeta Inc Business Overview
 Table 79. AbelZeta Inc Tumor Infiltrating Lymphocyte (TIL) Product
 Table 80. AbelZeta Inc Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 81. AbelZeta Inc Recent Development
 Table 82. WuXi AppTec Company Details
 Table 83. WuXi AppTec Business Overview
 Table 84. WuXi AppTec Tumor Infiltrating Lymphocyte (TIL) Product
 Table 85. WuXi AppTec Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 86. WuXi AppTec Recent Development
 Table 87. Oricell Therapeutics Company Details
 Table 88. Oricell Therapeutics Business Overview
 Table 89. Oricell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product
 Table 90. Oricell Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 91. Oricell Therapeutics Recent Development
 Table 92. Guangzhou Biosyngen Company Details
 Table 93. Guangzhou Biosyngen Business Overview
 Table 94. Guangzhou Biosyngen Tumor Infiltrating Lymphocyte (TIL) Product
 Table 95. Guangzhou Biosyngen Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 96. Guangzhou Biosyngen Recent Development
 Table 97. Shanghai Juncell Therapeutics Company Details
 Table 98. Shanghai Juncell Therapeutics Business Overview
 Table 99. Shanghai Juncell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product
 Table 100. Shanghai Juncell Therapeutics Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 101. Shanghai Juncell Therapeutics Recent Development
 Table 102. GRIT Biotechnology Company Details
 Table 103. GRIT Biotechnology Business Overview
 Table 104. GRIT Biotechnology Tumor Infiltrating Lymphocyte (TIL) Product
 Table 105. GRIT Biotechnology Revenue in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025) & (US$ Million)
 Table 106. GRIT Biotechnology Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Tumor Infiltrating Lymphocyte (TIL) Picture
 Figure 2. Global Tumor Infiltrating Lymphocyte (TIL) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Type: 2024 VS 2031
 Figure 4. T-cells Features
 Figure 5. B-cells Features
 Figure 6. Natural Killer Cells Features
 Figure 7. Global Tumor Infiltrating Lymphocyte (TIL) Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Application: 2024 VS 2031
 Figure 9. Melanoma Case Studies
 Figure 10. Colon Cancer Case Studies
 Figure 11. Cervical Cancer Case Studies
 Figure 12. Others Case Studies
 Figure 13. Tumor Infiltrating Lymphocyte (TIL) Report Years Considered
 Figure 14. Global Tumor Infiltrating Lymphocyte (TIL) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Tumor Infiltrating Lymphocyte (TIL) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Region: 2024 VS 2031
 Figure 17. Global Tumor Infiltrating Lymphocyte (TIL) Market Share by Players in 2024
 Figure 18. Global Top Tumor Infiltrating Lymphocyte (TIL) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Infiltrating Lymphocyte (TIL) as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Tumor Infiltrating Lymphocyte (TIL) Revenue in 2024
 Figure 20. North America Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Tumor Infiltrating Lymphocyte (TIL) Market Share by Country (2020-2031)
 Figure 22. United States Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Tumor Infiltrating Lymphocyte (TIL) Market Share by Country (2020-2031)
 Figure 26. Germany Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Tumor Infiltrating Lymphocyte (TIL) Market Share by Region (2020-2031)
 Figure 34. China Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Tumor Infiltrating Lymphocyte (TIL) Market Share by Country (2020-2031)
 Figure 42. Mexico Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Tumor Infiltrating Lymphocyte (TIL) Market Share by Country (2020-2031)
 Figure 46. Turkey Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Tumor Infiltrating Lymphocyte (TIL) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. IOVANCE Biotherapeutics Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 50. Optera Therapeutics Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 51. TILT Biotherapeutics Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 52. KSQ Therapeutics Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 53. Lion TCR Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 54. Beijing Chineo Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 55. AbelZeta Inc Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 56. WuXi AppTec Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 57. Oricell Therapeutics Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 58. Guangzhou Biosyngen Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 59. Shanghai Juncell Therapeutics Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 60. GRIT Biotechnology Revenue Growth Rate in Tumor Infiltrating Lymphocyte (TIL) Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Tumor Infiltrating Lymphocyte Therapy Market Research Report 2024
Global TIL Cell Therapy Market Research Report 2025
Global Novel T Cell Immunotherapies Market Research Report 2024
Global Tumor Immunity Therapy Market Research Report 2024
Global Immune Checkpoint Agents Market Research Report 2025
Global Circulating Tumor Cell Detector Market Research Report 2024
Global Cell Based Immunotherapy Market Research Report 2024
Global Cutaneous Tcell Lymphoma Market Research Report 2024
Circulating Tumor Cell CTC Detection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Circulating Tumor Cell Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lymph Cancer Testing Market Research Report 2024
Global T Lymphocyte Activation Antigen CD86 Market Research Report 2024
Neoantigen Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Microbiome Market Research Report 2024
Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024
Global Immune Checkpoint Blockers Market Research Report 2025
Cancer Immunotherapy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tumor Immunotherapy Market
Circulating Tumor Cell Detection Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Microbiome Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions